Q3 2026 13F filing
Updated 6 days ago67 disclosed positions worth $2.3B
Full holdings
Every line item disclosed in Q3 2026
| # | Stock | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|---|
| 1 | N NATERA INC | $640.7M | 1.55M | 27.84% | — |
| 2 | G GENMAB A/S | $155.2M | 4.35M | 6.74% | — |
| 3 | E ISHARES TR | $138.9M | 500.0K | 6.04% | — |
| 4 | J JAZZ PHARMACEUTICALS PLC | $97.8M | 422.4K | 4.25% | — |
| 5 | V VERA THERAPEUTICS INC | $90.2M | 2.79M | 3.92% | — |
| 6 | A AXSOME THERAPEUTICS INC. | $82.2M | 445.9K | 3.57% | — |
| 7 | S SEAPORT THERAPEUTICS INC | $71.9M | 3.56M | 3.12% | — |
| 8 | R RAPPORT THERAPEUTICS INC | $64M | 1.90M | 2.78% | — |
| 9 | A ASTRAZENECA PLC | $61.9M | 383.1K | 2.69% | — |
| 10 | Q INVESCO QQQ TR | $55.5M | 75.0K | 2.41% | — |
| 11 | A ARRIVENT BIOPHARMA INC | $51.4M | 1.70M | 2.23% | — |
| 12 | R RHYTHM PHARMACEUTICALS INC | $50.9M | 534.5K | 2.21% | — |
| 13 | L ELI LILLY & CO | $50.7M | 43.8K | 2.20% | — |
| 14 | C BRISTOL-MYERS SQUIBB CO | $43.7M | 700.0K | 1.90% | — |
| 15 | D DYNE THERAPEUTICS INC | $40.5M | 2.51M | 1.76% | — |
| 16 | I INHIBRX BIOSCIENCES INC | $39.2M | 391.6K | 1.70% | — |
| 17 | I IDEAYA BIOSCIENCES INC | $36.4M | 946.3K | 1.58% | — |
| 18 | I IMMUNOME INC | $35M | 1.63M | 1.52% | — |
| 19 | I IMMATICS N.V | $31.5M | 3.59M | 1.37% | — |
| 20 | N NOVARTIS AG | $28M | 196.7K | 1.22% | — |
| 21 | A ALNYLAM PHARMACEUTICALS INC | $27.9M | 112.9K | 1.21% | — |
| 22 | R ULTRAGENYX PHARMACEUTICAL IN | $26.4M | 1.75M | 1.15% | — |
| 23 | B BIOMARIN PHARMACEUTICAL INC | $26M | 432.7K | 1.13% | — |
| 24 | C BRISTOL-MYERS SQUIBB CO | $20.6M | 330.0K | 0.89% | — |
| 25 | A ABBOTT LABORATORIES | $20.5M | 207.0K | 0.89% | — |
| 26 | U UNITED THERAPEUTICS CORP DEL | $19.8M | 36.5K | 0.86% | — |
| 27 | P PHARVARIS N V | $19.7M | 621.7K | 0.86% | — |
| 28 | M VERADERMICS INC | $17.5M | 144.1K | 0.76% | — |
| 29 | A ANAPTYSBIO INC | $16.6M | 330.4K | 0.72% | — |
| 30 | B BIOAGE LABS INC | $16.3M | 2.29M | 0.71% | — |
| 31 | R ARCUS BIOSCIENCES INC | $16.2M | 626.2K | 0.70% | — |
| 32 | E EDGEWISE THERAPEUTICS INC | $16.1M | 396.6K | 0.70% | — |
| 33 | I IDEXX LABS INC | $15.2M | 29.1K | 0.66% | — |
| 34 | I DISC MEDICINE INC | $15.2M | 231.6K | 0.66% | — |
| 35 | D DESIGN THERAPEUTICS INC | $14.4M | 1.14M | 0.63% | — |
| 36 | B BIOGEN INC | $14.2M | 63.0K | 0.62% | — |
| 37 | T FIRST TRACKS BIOTHERAPEUTICS | $13.6M | 383.6K | 0.59% | — |
| 38 | N NEKTAR THERAPEUTICS | $13.2M | 218.0K | 0.57% | — |
| 39 | I DISC MEDICINE INC | $13.1M | 200.0K | 0.57% | — |
| 40 | D DEFINIUM THERAPEUTICS INC | $12.9M | 339.0K | 0.56% | — |
| 41 | N NURIX THERAPEUTICS INC | $12.4M | 523.7K | 0.54% | — |
| 42 | E EDGEWISE THERAPEUTICS INC | $12.2M | 300.0K | 0.53% | — |
| 43 | E ERASCA INC | $9.9M | 677.0K | 0.43% | — |
| 44 | N NEKTAR THERAPEUTICS | $9.1M | 150.0K | 0.39% | — |
| 45 | T TARSUS PHARMACEUTICALS INC | $8.7M | 110.1K | 0.38% | — |
| 46 | ? N/A DAMORA THERAPEUTICS INC | $3.2M | 149.2K | 0.14% | — |
| 47 | Q UNIQURE NV | $2.9M | 119.1K | 0.13% | — |
| 48 | A ANNEXON INC | $2.3M | 555.3K | 0.10% | — |
| 49 | S SILENCE THERAPEUTICS PLC | $2.3M | 211.8K | 0.10% | — |
| 50 | S SAVARA INC | $1.8M | 356.2K | 0.08% | — |